Scott Savage

Title: Scott Savage: Innovator in Pharmaceutical Development

Introduction

Scott Savage is a notable inventor based in Redwood City, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for chronic liver diseases. With a total of two patents to his name, his work has the potential to impact many lives.

Latest Patents

Scott Savage's latest patents include innovative formulations and methods related to neutrophil elastase inhibitors. One of his patents focuses on polymorphs and solid forms of (S)-2-2((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production. Another significant patent involves the use of neutrophil elastase inhibitors in treating chronic liver diseases, specifically nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). This invention also encompasses pharmaceutical compositions that include these inhibitors.

Career Highlights

Throughout his career, Scott has worked with prominent companies in the pharmaceutical industry, including Ph Pharma Co., Ltd. and Genentech, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Scott has collaborated with notable professionals in his field, including Sanjeev Satyal and Brian K. Roberts. These partnerships have likely enhanced his research and development efforts.

Conclusion

Scott Savage is a dedicated inventor whose work in pharmaceuticals is paving the way for new treatments for chronic liver diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.